HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.

Abstract
The objective of this study was to determine the efficacy of systemic colistin therapy in the treatment of nosocomial infections caused by multidrug-resistant Acinetobacter baumannii or Pseudomonas aeruginosa and to study related adverse events. We prospectively studied 78 infections caused by multidrug-resistant A. baumannii or P. aeruginosa that were treated with colistin. The sites of infection were pulmonary infection (78.2%), urinary tract infection (7.7%), primary bloodstream infection (11.5%) and meningitis (2.6%). The mean daily dose of colistin was 5.5+/-1.1 MU/day (range 2-9 MU/day) and the mean duration of colistin therapy was 9.3+/-3.8 days (range 5-21 days). A favourable clinical response to colistin occurred in 60 cases (76.9%). Renal failure occurred in only seven cases. We conclude that colistin can be a safe and effective salvage therapeutic option for nosocomial infections caused by multidrug-resistant A. baumannii or P. aeruginosa.
AuthorsHatem Kallel, Mabrouk Bahloul, Leila Hergafi, Malek Akrout, Wajdi Ketata, Hedi Chelly, Chokri Ben Hamida, Noureddine Rekik, Adnane Hammami, Mounir Bouaziz
JournalInternational journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 28 Issue 4 Pg. 366-9 (Oct 2006) ISSN: 0924-8579 [Print] Netherlands
PMID16971093 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Colistin
Topics
  • Acinetobacter Infections (drug therapy)
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Colistin (administration & dosage, therapeutic use)
  • Cross Infection (drug therapy)
  • Drug Resistance, Multiple, Bacterial
  • Humans
  • Intensive Care Units
  • Prospective Studies
  • Pseudomonas Infections (drug therapy)
  • Salvage Therapy
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: